Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Will the FY2002 Medical Fee Revision Promote Use of Generics? - Strategies of Major GE Makers - （2）
May 27, 2002
- Nat'l Exam for Physicians to Be Made More Accessible to the Handicapped
May 27, 2002
- Terumo: Sales Up 6.3% to \187,082 Mil.
May 27, 2002
- Wholesalers to Assist Makers in Immediate PMS
May 27, 2002
- General Risk Managers Appointed at All Nat'l Univ. Hospitals
May 27, 2002
- Olympus: New Digital Microscope "MIC-D"
May 27, 2002
- JPMA Committee to Promote Patient-friendly Healthcare
May 20, 2002
- Kobe Foundation, Kirin to Commercialize Cord Blood Stem Cells
May 20, 2002
- Importance of Drug Patents Emphasized: Union Symposium
May 20, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
May 20, 2002
- Teijin to Form Teijin Pharma by Spinning Off Drug Division in 2003
May 20, 2002
- Terumo to Transfer Dialyzer Business to Asahi Medical
May 20, 2002
- BUSINESS NEWS IN BRIEF
May 20, 2002
- Freund: US Subsidiary Boosts Sales, Profits
May 20, 2002
- NEW PRODUCTS
May 20, 2002
- Koike Sanso to Market Infectious Medical Waste Disposal System
May 20, 2002
- Research Starts on Humanized Antibodies for Treatment of Hepatitis C: Korosho
May 20, 2002
- MEDICAL DEVICE NEWS IN BRIEF
May 20, 2002
- REGULATORY NEWS IN BRIEF
May 20, 2002
- Sanko Junyaku to Create New Company to Commercialize PALSAR Method
May 20, 2002
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…